Efficacy of domperidone and/or omeprazole in the treatment of gastroesophageal reflux in children - a comparative study.
DEC-NET Serial number GB279
Published online07/07/2004 14.46.00
Last updated02/08/2005 14.06.13
Other protocol ID numberN0264130004
This trial has been approved by an ethics committee
Current trial statusOpen (actively recruiting new participants)
Major Disease
(ICD9 class)
ESOPHAGEAL REFLUX
Experimental drug
DOMPERIDONE
Omeprazole
GenderBoth
Age (range)<16 years

Eligibility criteria
Inclusion criteria
Children under 16 with a reflux index >1
Exclusion criteria
Informed consent not given

Trial design/methodology
Phase3
Kind of studyEfficacy
DesignControlled
Randomised
Blinded
Double blind
Purpose of study
To document the efficacy of domperidone and/or omeprazole in neurologically normal and abnormal children found to have significant GOR on oesophageal pH monitoring
Summary of study design, objectives, and ongoing research findings
Double blind placebo controlled prospective randomised controlled trial. Randomised to A]domperidone B]omeprazole C]combination of both. The aim of the study is to document the efficacy of domperidone and/or omeprazole in neurologically normal and abnormal children found to have significant GOR on oesophageal pH monitoring
Principal investigator
NameProfessor B K Sandhu
InstitutionBristol Royal Infirmary
Postal addressC/O Research & Effectiveness Department, Level 1, The Old Building, Bristol Royal Infirmary, Malborough Street, BRISTOL, BS2 8HW
CityBRISTOL
CountryUNITED KINGDOM
Phone0117 928 3473
Fax0117 928 3524
E-mailr&eoffice@ubht.swest.nhs.uk


Sponsor name
United Bristol Healthcare NHS Trust (Academic Institution)

ISRCTN  EudraCT